Scotiabank initiated coverage of Amgen (AMGN) with an Outperform rating and $385 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- QQQ ETF News, 11/12/2025
- Quantum Computing News: DARPA Picks 11 Startups, Quantinuum Unveils Helios, LG Bets on Pasqal
- Amgen announces results from Phase 3 VESALIUS-CV trial
- Amgen price target raised to $315 from $305 at Cantor Fitzgerald
- Amgen Stock Overvaluation Concerns Amid Mixed Future Guidance and Pipeline Delays